DK0673250T3 - Ophthalmiske præparater omfattende emedastin og deres anvendelse til behandling af allergisk conjunctivitis - Google Patents

Ophthalmiske præparater omfattende emedastin og deres anvendelse til behandling af allergisk conjunctivitis

Info

Publication number
DK0673250T3
DK0673250T3 DK94903534T DK94903534T DK0673250T3 DK 0673250 T3 DK0673250 T3 DK 0673250T3 DK 94903534 T DK94903534 T DK 94903534T DK 94903534 T DK94903534 T DK 94903534T DK 0673250 T3 DK0673250 T3 DK 0673250T3
Authority
DK
Denmark
Prior art keywords
allergic conjunctivitis
emedastine
treatment
ophthalmic preparations
homopiperazinyl
Prior art date
Application number
DK94903534T
Other languages
English (en)
Inventor
Shigetoshi Okumura
Stella M Robertson
Tadayuki Saito
Hitoshi Tanaka
John M Yanni
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of DK0673250T3 publication Critical patent/DK0673250T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94903534T 1992-12-09 1993-12-08 Ophthalmiske præparater omfattende emedastin og deres anvendelse til behandling af allergisk conjunctivitis DK0673250T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32921692A JP3527256B2 (ja) 1992-12-09 1992-12-09 抗アレルギー点眼剤
PCT/US1993/011939 WO1994013299A1 (en) 1992-12-09 1993-12-08 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis

Publications (1)

Publication Number Publication Date
DK0673250T3 true DK0673250T3 (da) 1999-12-27

Family

ID=18218955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94903534T DK0673250T3 (da) 1992-12-09 1993-12-08 Ophthalmiske præparater omfattende emedastin og deres anvendelse til behandling af allergisk conjunctivitis

Country Status (13)

Country Link
US (1) US5441958A (da)
EP (1) EP0673250B1 (da)
JP (1) JP3527256B2 (da)
KR (1) KR100275016B1 (da)
AT (1) ATE185696T1 (da)
AU (1) AU667613B2 (da)
CA (1) CA2151385C (da)
DE (1) DE69326840T2 (da)
DK (1) DK0673250T3 (da)
ES (1) ES2137352T3 (da)
GR (1) GR3032264T3 (da)
TW (1) TW257676B (da)
WO (1) WO1994013299A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
ATE291913T1 (de) 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
JP2002249445A (ja) * 2000-12-19 2002-09-06 Ophtecs Corp 眼科用液剤組成物
ES2258175T3 (es) * 2001-12-05 2006-08-16 Alcon, Inc. Utilizacion de un antagonista de h1 y remixolona como esteroide inofensivo para el tratamiento de la rinitis.
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
GB2503687B (en) 2012-07-04 2018-02-21 Dyson Technology Ltd An attachment for a hand held appliance
EP2869726B1 (en) 2012-07-04 2020-04-01 Dyson Technology Limited Hairdryer with an attachment
CA3088740A1 (en) 2018-01-18 2019-07-25 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPH0383924A (ja) * 1989-08-28 1991-04-09 Kanebo Ltd 経皮投与用組成物
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines

Also Published As

Publication number Publication date
DE69326840D1 (de) 1999-11-25
GR3032264T3 (en) 2000-04-27
EP0673250B1 (en) 1999-10-20
KR940013505A (ko) 1994-07-15
ATE185696T1 (de) 1999-11-15
US5441958A (en) 1995-08-15
JPH06172179A (ja) 1994-06-21
TW257676B (da) 1995-09-21
KR100275016B1 (ko) 2000-12-15
CA2151385A1 (en) 1994-06-23
JP3527256B2 (ja) 2004-05-17
AU5744294A (en) 1994-07-04
HK1013964A1 (en) 1999-09-17
WO1994013299A1 (en) 1994-06-23
DE69326840T2 (de) 2000-04-20
ES2137352T3 (es) 1999-12-16
CA2151385C (en) 1999-02-09
EP0673250A1 (en) 1995-09-27
AU667613B2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
DK0858330T3 (da) Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
FI944549A7 (fi) Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
DE69818049D1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
DK0559743T3 (da) Nye hydroxamsyre- og N-hydroxyurinstofderivater og deres anvendelse
NO971902D0 (no) Bindingsmidler til CD23
DK0804437T3 (da) [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
DE69326840D1 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
DK1144365T3 (da) Inhibitorer af alfa4beta1-medieret celleadhæsion
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
IS2860B (is) Veirueyðandi samsetningar
DK0549666T3 (da) Nye aminobenzosultamderivater og deres anvendelse som lipoxygenaseinhibitorer
DK1635776T5 (da) Lipidoverf ringsproteinsystemer samt deres kosmetiske dermatologiske anvendelse
DK227090A (da) Organisk guldkompleks til topisk anvendelse
PT727996E (pt) Formulacoes de febbendazol
MX9302951A (es) Composicion farmaceutica para tratar la hiperproliferacion celular.
ATE108993T1 (de) Lichtschutz.
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА